SCHEMBL29051705

SCHEMBL29051705

CS(=O)(=O)Nc1ncccc1CNc1nc(Nc2ccc3c(c2)CCN(C(=O)O)C3)ncc1C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 13/20 0.58
▸ CHEK1 O14757 12/20 0.58
▸ PTK2 Q05397 8/20 0.54
▸ PTK2B Q14289 3/20 0.54
▸ AURKA O14965 2/20 0.54
▸ RPS6KB1 P23443 2/20 0.54
▸ CDK2 P24941 2/20 0.54
▸ RPS6KA3 P51812 2/20 0.54
▸ IRAK4 Q9NWZ3 2/20 0.54
▸ PLK4 O00444 1/20 0.54
▸ PDPK1 O15530 1/20 0.54
▸ DAPK3 O43293 1/20 0.54
▸ JAK2 O60674 1/20 0.54
▸ ROCK2 O75116 1/20 0.54
▸ STK16 O75716 1/20 0.54
▸ PRKD3 O94806 1/20 0.54
▸ MAP4K4 O95819 1/20 0.54
▸ PAK4 O96013 1/20 0.54
▸ CHEK2 O96017 1/20 0.54
▸ NTRK1 P04629 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29051865 0.91 FLT3 (0.47) FLT3CHEK1PTK2PTK2BAURKA
SCHEMBL29051940 0.90 FLT3 (0.46) FLT3CHEK1PTK2PTK2BAURKA
SCHEMBL29052266 0.89 INSR (0.46) FLT3CHEK1PTK2PTK2BNTRK1
SCHEMBL29051857 0.87 PTK2 (0.47) FLT3CHEK1PTK2PTK2BAURKA
SCHEMBL29052199 0.80 FLT3 (0.49) FLT3CHEK1AURKARPS6KB1CDK2
SCHEMBL29051738 0.80 PTK2 (0.50) FLT3CHEK1PTK2INSRMET
SCHEMBL29051729 0.80 FLT3 (0.48) FLT3CHEK1JAK2TYK2JAK3
SCHEMBL29052169 0.78 CHEK1 (0.56) FLT3CHEK1PTK2AURKARPS6KB1
SCHEMBL26098324 0.78 FLT3 (0.63) FLT3CHEK1RPS6KB1KIT
SCHEMBL29052136 0.77 FLT3 (0.46) FLT3CHEK1PTK2PTK2BAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116332910-A 2-aminopyrimidine derivatives as kinase inhibitors, preparation and use thereof 江苏威凯尔医药科技有限公司 2023-06-27 — — CN disclosed
Send feedback